Trinity Biotech plc (TRIB) |
|
0.975 -0.024 (-2.45%)
|
02-14 16:00 |
|
Open: |
1.02 |
Pre. Close: |
0.9995 |
|
High:
|
0.9913 |
Low:
|
0.9064 |
|
Volume:
|
104,668 |
Market Cap:
|
21M |
|
|
|
|
Trinity Biotech PLC develops, manufactures and markets clinical diagnostic products. Its products are used for detecting autoimmune, sexually transmitted diseases, diabetes and disorders of the liver. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.022 - 1.029 |
1.029 - 1.034 |
|
Low:
|
0.893 - 0.902 |
0.902 - 0.909 |
|
Close:
|
0.967 - 0.98 |
0.98 - 0.99 |
|
Technical analysis |
as of: 2020-02-14 4:33:11 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.70  One year: 2.09 |
| Support: |
Support1: 0.91 Support2: 0.75 |
| Resistance: |
Resistance1: 1.45 Resistance2: 1.79 |
| Pivot: |
1.13 |
| Moving Average: |
MA(5): 1.05 MA(20): 1.16
MA(100): 1.02 MA(250): 1.76 |
| MACD: |
MACD(12,26): -0.01 Signal(9): 0.01 |
| Stochastic oscillator: |
%K(14,3): 5.48  %D(3): 6.40 |
| RSI: |
RSI(14): 39.33 |
| 52-week: |
High: 3.36 Low: 0.63 Change(%): -63.5 |
| Average Vol(K): |
3-Month: 13476 10-Days: 16327 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.TRIB has closed above bottom band by 1.5%. Bollinger Bands are 0.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-10-04
The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed on Thursday) Viela Bio Incn (NASDAQ: VIE ) (IPOed on Thursday) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 3) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) bluebird bio Inc . (NASDAQ: BLUE ) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) DelMar Pharmaceuticals Inc (NASDAQ: DMP ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Erytech Pharma SA (NASDAQ: ERYP ) Frequency Therapeutics Inc (NASDAQ: FREQ )(IPOed on Thursday) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Jaguar Health Inc (NASDAQ: JAGX ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) Neuralstem, Inc. (NASDAQ: CUR ) Obseva SA (NASDAQ: OBSV ) Onconova Therapeutics Inc (NASDAQ: ONTX ) RA Medical Systems Inc (NYSE: RMED ) Sierra Oncology Inc (NASDAQ: SRRA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Trinity Biotech plc (NASDAQ: TRIB ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus Arbutus Halts Hepatitis B Drug Study Arbutus Biopharma Corp (NASDAQ: ABUS ) decided to discontinue the development of AB-506, an oral capsid inhibitor, which was being evaluated in a Phase 1a/1b trial for the treatment …
2019-09-13
The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 11) Ardelyx Inc (NASDAQ: ARDX ) Avedro Inc (NASDAQ: AVDR ) Celgene Corporation (NASDAQ: CELG ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) The Medicines Company (NASDAQ: MDCO ) Medtronic PLC (NYSE: MDT ) Nevro Corp (NYSE: NVRO ) Radius Health Inc (NASDAQ: RDUS ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 11) CELYAD SA/ADR (NASDAQ: CYAD ) Endologix, Inc. (NASDAQ: ELGX ) Myovant Sciences Ltd (NYSE: MYOV ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Titan Pharmaceuticals, Inc. common stock (NASDAQ: TTNP )(filed for a $12 million secondary offering) Tocagen Inc (NASDAQ: TOCA )( reported that its late-stage brain cancer study did not meet the primary endpoint) Trinity Biotech plc (NASDAQ: TRIB ) Stocks In Focus Ardelyx Gets FDA Nod For Constipation Drug Ardelyx announced the FDA has approved its tenapanor, brand name Ibsrela, a 50mg twice-daily oral pill for the treatment of irritable bowel syndrome with constipation in adults.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Diagnostics Research |
| Shares Out. (M) |
20.90 |
| Shares Float (M) |
14.28 |
|
% Held by Insiders
|
18.25 |
|
% Held by Institutions
|
46.78 |
|
Shares Short (K)
|
138 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.414 |
|
Book Value (p.s.)
|
1.860 |
|
PEG Ratio
|
0.47 |
|
Profit Margin
|
-31.56 |
|
Operating Margin
|
6.19 |
|
Return on Assets (ttm)
|
2.0 |
|
Return on Equity (ttm)
|
-56.3 |
|
Qtrly Rev. Growth
|
3.7 |
|
Gross Profit (p.s.)
|
1.983 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
0.366 |
|
Qtrly Earnings Growth
|
-97.20 |
|
Operating Cash Flow (M)
|
11.00 |
|
Levered Free Cash Flow (M)
|
-1.47 |
Stock Valuations |
|
P/E
|
-0.69 |
|
P/E Growth Ratio
|
-0.03 |
|
P/BV
|
0.52 |
|
P/S
|
0.21 |
|
P/CF
|
1.85 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2015-06-30 |
|
Ex-Dividend Date
|
2015-06-04 |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
0.25 |
|
7 Binary Options
|
|
Your Ad Here
|
|
